Rethinking clinical delivery of adult stem cell therapies

Does the FDA have regulatory authority over adult autologous stem cell therapies? 21 CFR 1271 and the emperor's new clothes

(2012) Michael Freeman et al.   Journal of Translational Medicine

Concise Review: Immunomodulatory Properties of Mesenchymal Stem Cells in Cellular Transplantation: Update, Controversies, and Unknowns

(2012) Rony Atoui et al.   Stem Cells Translational Medicine

Regenerative Medicine

(2011) Jason P. Glotzbach et al.   CURRENT PROBLEMS IN SURGERY

Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies

(2011) D. L. Porter   Hematology-American Society of Hematology Education Program

Bioreactor based engineering of large-scale human cartilage grafts for joint resurfacing

(2010) Rosaria Santoro et al.   BIOMATERIALS

Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair

(2010) Xi-Ping Huang et al.   CIRCULATION

Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products

(2009) Ivan Martin et al.   TRENDS IN BIOTECHNOLOGY